Exchange & Returns Information
Review Details
(24)
| Drug Type | Original |
|---|---|
| Active Ingredient | SEMAGLUTIDE |
| Strength | 1MG |
| Manufacturer | NOVO NORDISK |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 1 PEN | $ 147.00 | $ 147.00 |
$ 124.95
Apply ZARVY26 (-15%)
You save $ 22.05
|
||
| 2 BOXES - 2 PENS | $ 104.50 |
29% $ 294.00
$ 209.00
|
$ 177.65
Apply ZARVY26 (-15%)
You save $ 31.35
|
||
| ★ Best Value 3 BOXES - 3 PENS | $ 89.67 |
39% $ 441.00
$ 269.00
|
$ 228.65
Apply ZARVY26 (-15%)
You save $ 40.35
|
Reference information will be available soon.
Ozempic 1mg Prefilled Pen is the maximum approved weekly dose of semaglutide for the treatment of type 2 diabetes mellitus. It is a once-weekly injectable GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, and delays gastric emptying. This triple mechanism helps lower both fasting and postprandial glucose levels. The 1mg dose is generally prescribed after titration through lower doses (0.25mg → 0.5mg) and is intended for patients who require enhanced glycemic control beyond the 0.5mg regimen. While semaglutide also reduces appetite and contributes to weight reduction, Ozempic is not approved by the FDA for obesity treatment. Any weight-related outcomes should be considered off-label and incidental.
- DIABETES (GLP-1 Receptor Agonists) > Ozempic 1mg is indicated for the treatment of adults with type 2 diabetes to improve glycemic control. It may be used as monotherapy in metformin-intolerant patients or in combination with other oral hypoglycemics. The 1mg dose is especially useful in patients who do not achieve sufficient glucose control with the 0.5mg dose. It also offers the added benefit of reducing cardiovascular risks in diabetic individuals with existing heart conditions. - DIET (Metabolic Weight Control) > Although semaglutide has been shown to support weight reduction through appetite suppression and delayed gastric emptying, Ozempic is not FDA-approved for weight management. Off-label use exists in practice, but the appropriate indication for obesity is covered under Wegovy. Any mention of weight loss in the context of Ozempic must be positioned as a secondary, unintended effect.
Semaglutide is a long-acting GLP-1 receptor agonist that mimics the body’s natural incretin response. Upon injection, it binds to GLP-1 receptors on pancreatic beta cells, stimulating insulin release when blood glucose is elevated. Simultaneously, it inhibits glucagon secretion, thereby reducing hepatic glucose output. It also delays gastric emptying, promoting satiety and leading to reduced food intake. The 1mg dose ensures maximum glycemic efficacy while maintaining a favorable safety profile. It is ideal for long-term glycemic maintenance in patients requiring intensified therapy.
→ Subcutaneous Injection for Type 2 Diabetes (Ozempic-specific): - Week 1–4: 0.25 mg SC once weekly (initiation phase) - Week 5–8: 0.5 mg SC once weekly - Week 9 and beyond: 1.0 mg SC once weekly *(This product applies here)* - Max Dose: 1.0 mg per week → Switching Guidance: - From oral semaglutide (14 mg): initiate Ozempic 0.5 mg SC first, then titrate to 1.0 mg - No oral equivalent currently exists for the 1.0 mg SC dose - Switching from 0.5 mg Ozempic to 1.0 mg requires at least 4 weeks of stable response at 0.5 mg → Indication Criteria: - Adults with type 2 diabetes requiring enhanced glycemic control - Patients with elevated HbA1c despite lower-dose therapy - Individuals with type 2 diabetes and existing cardiovascular disease → Off-Label Use for Weight Loss: - Ozempic 1mg is not approved for weight loss; weight reduction, if observed, is incidental - Patients seeking weight loss as a primary goal should consider semaglutide 2.4 mg (Wegovy)
Store unopened pens in a refrigerator at 2–8°C. Do not freeze. Once opened, the pen may be stored at room temperature (below 30°C) for up to 56 days. Protect from sunlight and heat. Keep away from children and pets.
The most commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, and loss of appetite, particularly during dose escalation. Other reactions may include dyspepsia, fatigue, dizziness, and injection site irritation. Serious but rare complications may involve acute pancreatitis, gallbladder disease, or renal impairment secondary to dehydration. Hypoglycemia is rare when used alone but may occur when combined with sulfonylureas or insulin. Patients should be advised to monitor symptoms and consult their provider if severe gastrointestinal issues persist.
I'm not chasing numbers on a scale, but it's a great feeling when your clothes start to fit better.
升级到1毫克的诺和泰，效果很稳定。这家网站每月都能准时发货，让我可以安心地进行我的健康管理。
Had a check-up and my doctor is thrilled with my progress. This medication has been a great tool.
What I value most about this service is the peace of mind. Every month, I place my order for the next dose—this time 1mg—and I know with 100% certainty that it will arrive on time and in perfect condition. This consistency has been a foundational part of my success in managing my diabetes. My energy is more stable, my doctor is happy, and I feel better than I have in a long time. This pharmacy plays a huge role in that.
My third month's Ozempic pen arrived right on schedule. This service is consistently reliable.
No combo deals available at the moment.
